English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

S. Bacon 1, M.P. Kyithar1, S.R. Rizvi1, E. Donnelly 1, A. McCarthy1, M. Burke1, K. Colclough 2, S. Ellard2,3, M.M. Byrne1 1 Department of Diabetes & Endocrinology, Mater Misericordiae University Hospital, Dublin 7, Ireland. 2Department of Molecular Genetics, Royal Devon & Exeter NHS Foundation Trust, Exeter. U.K, 3Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.

endocrine abstracts

Optimal glycaemic control and a low rate of micro and macrovascular complications in patients with HNF1A-MODY treated in a dedicated tertiary referral centre